CDC25B and papillary carcinoma: In papillary carcinoma, 44 of the 72 cases (61.1%) overexpressed cdc25B (Figure 1C), indicating that this phenomenon was observed in 74 of the 121 cases (61.2%) of papillary or follicular carcinoma.